nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Burning sensation—Thalidomide—leprosy	0.0308	0.0308	CcSEcCtD
Brimonidine—Cyanosis—Thalidomide—leprosy	0.0302	0.0302	CcSEcCtD
Brimonidine—Nasopharyngitis—Dapsone—leprosy	0.0271	0.0271	CcSEcCtD
Brimonidine—Influenza—Dapsone—leprosy	0.0262	0.0262	CcSEcCtD
Brimonidine—Acne—Thalidomide—leprosy	0.0254	0.0254	CcSEcCtD
Brimonidine—Apnoea—Thalidomide—leprosy	0.0252	0.0252	CcSEcCtD
Brimonidine—Vasodilation—Thalidomide—leprosy	0.0243	0.0243	CcSEcCtD
Brimonidine—Vasodilation procedure—Thalidomide—leprosy	0.0243	0.0243	CcSEcCtD
Brimonidine—Arthropathy—Thalidomide—leprosy	0.0235	0.0235	CcSEcCtD
Brimonidine—Hypercholesterolaemia—Thalidomide—leprosy	0.0226	0.0226	CcSEcCtD
Brimonidine—Sinusitis—Dapsone—leprosy	0.0219	0.0219	CcSEcCtD
Brimonidine—Pharyngitis—Dapsone—leprosy	0.0208	0.0208	CcSEcCtD
Brimonidine—Dry eye—Thalidomide—leprosy	0.0198	0.0198	CcSEcCtD
Brimonidine—Erythema—Dapsone—leprosy	0.0183	0.0183	CcSEcCtD
Brimonidine—Diabetes mellitus—Thalidomide—leprosy	0.0179	0.0179	CcSEcCtD
Brimonidine—Vision blurred—Dapsone—leprosy	0.0172	0.0172	CcSEcCtD
Brimonidine—Eye pain—Thalidomide—leprosy	0.0172	0.0172	CcSEcCtD
Brimonidine—Visual disturbance—Thalidomide—leprosy	0.0164	0.0164	CcSEcCtD
Brimonidine—Arthritis—Thalidomide—leprosy	0.016	0.016	CcSEcCtD
Brimonidine—Cough—Dapsone—leprosy	0.0159	0.0159	CcSEcCtD
Brimonidine—Lethargy—Thalidomide—leprosy	0.0158	0.0158	CcSEcCtD
Brimonidine—Osteoarthritis—Thalidomide—leprosy	0.0155	0.0155	CcSEcCtD
Brimonidine—Face oedema—Thalidomide—leprosy	0.015	0.015	CcSEcCtD
Brimonidine—Tachycardia—Dapsone—leprosy	0.0146	0.0146	CcSEcCtD
Brimonidine—Dry skin—Thalidomide—leprosy	0.0142	0.0142	CcSEcCtD
Brimonidine—Insomnia—Dapsone—leprosy	0.0135	0.0135	CcSEcCtD
Brimonidine—Influenza—Thalidomide—leprosy	0.0134	0.0134	CcSEcCtD
Brimonidine—Bronchitis—Thalidomide—leprosy	0.0129	0.0129	CcSEcCtD
Brimonidine—Drowsiness—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Brimonidine—Depression—Thalidomide—leprosy	0.0119	0.0119	CcSEcCtD
Brimonidine—Conjunctivitis—Thalidomide—leprosy	0.0116	0.0116	CcSEcCtD
Brimonidine—Sinusitis—Thalidomide—leprosy	0.0112	0.0112	CcSEcCtD
Brimonidine—Bradycardia—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Brimonidine—Rhinitis—Thalidomide—leprosy	0.0108	0.0108	CcSEcCtD
Brimonidine—Pharyngitis—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Brimonidine—Visual impairment—Thalidomide—leprosy	0.0104	0.0104	CcSEcCtD
Brimonidine—Eye disorder—Thalidomide—leprosy	0.01	0.01	CcSEcCtD
Brimonidine—Cardiac disorder—Thalidomide—leprosy	0.00997	0.00997	CcSEcCtD
Brimonidine—Angiopathy—Thalidomide—leprosy	0.00975	0.00975	CcSEcCtD
Brimonidine—Immune system disorder—Thalidomide—leprosy	0.0097	0.0097	CcSEcCtD
Brimonidine—Mediastinal disorder—Thalidomide—leprosy	0.00968	0.00968	CcSEcCtD
Brimonidine—Arrhythmia—Thalidomide—leprosy	0.0096	0.0096	CcSEcCtD
Brimonidine—Mental disorder—Thalidomide—leprosy	0.00941	0.00941	CcSEcCtD
Brimonidine—Headache—Dapsone—leprosy	0.00934	0.00934	CcSEcCtD
Brimonidine—Dysgeusia—Thalidomide—leprosy	0.00916	0.00916	CcSEcCtD
Brimonidine—Nausea—Dapsone—leprosy	0.00886	0.00886	CcSEcCtD
Brimonidine—Vision blurred—Thalidomide—leprosy	0.00881	0.00881	CcSEcCtD
Brimonidine—Syncope—Thalidomide—leprosy	0.00839	0.00839	CcSEcCtD
Brimonidine—Palpitations—Thalidomide—leprosy	0.00826	0.00826	CcSEcCtD
Brimonidine—Loss of consciousness—Thalidomide—leprosy	0.00822	0.00822	CcSEcCtD
Brimonidine—Cough—Thalidomide—leprosy	0.00816	0.00816	CcSEcCtD
Brimonidine—Hypertension—Thalidomide—leprosy	0.00807	0.00807	CcSEcCtD
Brimonidine—Chest pain—Thalidomide—leprosy	0.00796	0.00796	CcSEcCtD
Brimonidine—Myalgia—Thalidomide—leprosy	0.00796	0.00796	CcSEcCtD
Brimonidine—Arthralgia—Thalidomide—leprosy	0.00796	0.00796	CcSEcCtD
Brimonidine—Anxiety—Thalidomide—leprosy	0.00793	0.00793	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00791	0.00791	CcSEcCtD
Brimonidine—Discomfort—Thalidomide—leprosy	0.00787	0.00787	CcSEcCtD
Brimonidine—Dry mouth—Thalidomide—leprosy	0.00779	0.00779	CcSEcCtD
Brimonidine—Oedema—Thalidomide—leprosy	0.00763	0.00763	CcSEcCtD
Brimonidine—Infection—Thalidomide—leprosy	0.00758	0.00758	CcSEcCtD
Brimonidine—Shock—Thalidomide—leprosy	0.00751	0.00751	CcSEcCtD
Brimonidine—Nervous system disorder—Thalidomide—leprosy	0.00749	0.00749	CcSEcCtD
Brimonidine—Tachycardia—Thalidomide—leprosy	0.00745	0.00745	CcSEcCtD
Brimonidine—Skin disorder—Thalidomide—leprosy	0.00741	0.00741	CcSEcCtD
Brimonidine—Hypotension—Thalidomide—leprosy	0.00713	0.00713	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00695	0.00695	CcSEcCtD
Brimonidine—Insomnia—Thalidomide—leprosy	0.0069	0.0069	CcSEcCtD
Brimonidine—Paraesthesia—Thalidomide—leprosy	0.00685	0.00685	CcSEcCtD
Brimonidine—Dyspnoea—Thalidomide—leprosy	0.00681	0.00681	CcSEcCtD
Brimonidine—Somnolence—Thalidomide—leprosy	0.00679	0.00679	CcSEcCtD
Brimonidine—Dyspepsia—Thalidomide—leprosy	0.00672	0.00672	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Thalidomide—leprosy	0.00659	0.00659	CcSEcCtD
Brimonidine—Fatigue—Thalidomide—leprosy	0.00658	0.00658	CcSEcCtD
Brimonidine—Pain—Thalidomide—leprosy	0.00653	0.00653	CcSEcCtD
Brimonidine—Hypersensitivity—Thalidomide—leprosy	0.00562	0.00562	CcSEcCtD
Brimonidine—Asthenia—Thalidomide—leprosy	0.00548	0.00548	CcSEcCtD
Brimonidine—Pruritus—Thalidomide—leprosy	0.0054	0.0054	CcSEcCtD
Brimonidine—Dizziness—Thalidomide—leprosy	0.00505	0.00505	CcSEcCtD
Brimonidine—Rash—Thalidomide—leprosy	0.00481	0.00481	CcSEcCtD
Brimonidine—Dermatitis—Thalidomide—leprosy	0.00481	0.00481	CcSEcCtD
Brimonidine—Headache—Thalidomide—leprosy	0.00478	0.00478	CcSEcCtD
Brimonidine—Nausea—Thalidomide—leprosy	0.00453	0.00453	CcSEcCtD
